Product Information
TRELEGY ELLIPTA 100-62.5-25 is a brand product labeled by GlaxoSmithKline LLC, priced at $11.1192 per EA under NDC 00173088714. Its NADAC has been published 423 times since May 23, 2018.
TRELEGY ELLIPTA 100-62.5-25
fluticasone furoate, umeclidinium bromide and vilanterol trifenatateStrength
100; 62.5; 25 ug/1; ug/1; ug/1
Manufacturer
GlaxoSmithKline LLCNDC
00173088714
Classification
Brand
Dosage Form
POWDER
Route
RESPIRATORY (INHALATION)
Last Updated
6/17/2026
Active Ingredients
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATEApproval Type
New Drug (NDA)
FDA Application
NDA209482On Market Since
9/18/2017
Pharmacological Classes
Price Statistics
The NADAC for TRELEGY ELLIPTA 100-62.5-25 has been published 423 times since May 23, 2018, and over the history we have for it it has risen 31.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.1192 per EA |
|---|---|
| All-time high | $11.1502 (May 13, 2026) |
| All-time low | $8.4493 (May 23, 2018) |
| 52-week high | $11.1502 |
| 52-week low | $10.7995 |
| Median price | $9.9554 |
| Average price | $9.8276 |
| Largest weekly change | +5.0% (Jan 13, 2021) |
| Weeks tracked | 423 |
| Tracking since | May 23, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TRELEGY ELLIPTA 100-62.5-25?
The current National Average Drug Acquisition Cost (NADAC) for TRELEGY ELLIPTA 100-62.5-25, manufactured by GlaxoSmithKline LLC, is $11.1192 per EA (NDC 00173088714), effective Jun 24, 2026.
How has the price of TRELEGY ELLIPTA 100-62.5-25 changed over time?
Over the history we have for it, the NADAC for TRELEGY ELLIPTA 100-62.5-25 has risen 31.6%. It has been tracked across 423 weekly CMS publications since May 23, 2018.
What are the highest and lowest recorded NADAC prices for TRELEGY ELLIPTA 100-62.5-25?
Since May 23, 2018, the NADAC for TRELEGY ELLIPTA 100-62.5-25 has ranged from a low of $8.4493 (May 23, 2018) to a high of $11.1502 (May 13, 2026), with a median of $9.9554 per EA.
Are there cheaper alternatives to TRELEGY ELLIPTA 100-62.5-25?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TRELEGY ELLIPTA 100-62.5-25, but none are currently priced below it.
Who manufactures TRELEGY ELLIPTA 100-62.5-25?
TRELEGY ELLIPTA 100-62.5-25 (NDC 00173088714) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification